Meds & supplements › Atropine
Medicine
Atropine Sulfate Injection, USP, is indicated for temporary blockade of severe or life threatening muscarinic effects, e.g., as an antisialagogue, an antivagal agent, an antidote for organophosphorus or muscarinic mushroom poisoning
Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗
Atropine Sulfate Ophthalmic Solution, 1% is indicated in adults and pediatric patients aged three (3) months and older for:
1.1 Cycloplegia 1.2 Mydriasis 1.3 Penalization of the Healthy Eye in the Treatment of Amblyopia
The following serious adverse reactions are described below and elsewhere in the labeling:
sofidex [Internet]. Daloreum; c2026. Atropine; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/atropine
sofidex. (2026, August 2). Atropine. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/atropine
Atropine. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/atropine
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.